HIV-1 is the more common type of Human Immunodeficiency Virus found in the world as compared to HIV-2 which is less common and less contagious. Approximately 95% of the world population of HIV infected people is due to HIV-1. Once a person is diagnosed with HIV-1, treatment is required to stop further progression of the infection into AIDS. Viral Load Assays are beneficial here as they help to determine the viral load in the body and thereby help to determine which treatment option will work best for the patient. Abbott Molecular specializes in Viral Load Assays based on Real-Time PCR which work on Abbott m2000 systems.
Solutions from Abbott Molecular include:
- 1. Abbott Real Time HIV-1 Quantitative Assay: For adults
- 2. Abbott Real Time HIV-1 Qualitative Assay: For Early Infant Diagnosis
The Abbott RealTime HIV-1 assay is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay for the quantitation of Human Immunodeficiency Virus type 1 (HIV-1) on the automated m2000 System in human plasma from HIV-1 infected individuals over the range of 40 to 10,000,000 copies/mL. The Abbott RealTime HIV-1 assay is intended for use in conjunction with clinical presentation and other laboratory markers for disease prognosis and for use as an aid in assessing viral response to antiretroviral treatment as measured by changes in plasma HIV-1 RNA levels.ADD TO SHORTLIST